Cargando…
Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis
OBJECTIVE: Statins, a class of 3-hydroxy-3 methyl-glutaryl-coenzyme A reductase inhibitors, are widely used for the treatment of atherosclerosis. Less is known about the role of statins in the treatment of vascular complication in systemic sclerosis (SSc). We therefore performed a short-term interve...
Autor principal: | Kotyla, Przemyslaw J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991246/ https://www.ncbi.nlm.nih.gov/pubmed/29557229 http://dx.doi.org/10.1177/0300060518762681 |
Ejemplares similares
-
Necrobiotic Xanthogranuloma Coexists with Diffuse Normolipidemic Plane Xanthoma and Multiple Myeloma
por: Kim, Joon Goon, et al.
Publicado: (2020) -
Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis
por: Gumkowska-Sroka, Olga, et al.
Publicado: (2023) -
Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus
por: Kotyla, Przemysław, et al.
Publicado: (2022) -
Mutant LRP6 Impairs Endothelial Cell Functions Associated with Familial Normolipidemic Coronary Artery Disease
por: Guo, Jian, et al.
Publicado: (2016) -
Calcium Phosphate Bions Cause Intimal Hyperplasia in Intact Aortas of Normolipidemic Rats through Endothelial Injury
por: Shishkova, Daria, et al.
Publicado: (2019)